azacitidine and Frontotemporal Lobar Degeneration

azacitidine has been researched along with Frontotemporal Lobar Degeneration in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banzhaf-Strathmann, J; Claus, R; Cruts, M; De Deyn, PP; Edbauer, D; Engelborghs, S; Mücke, O; Plass, C; Rentzsch, K; van Broeckhoven, C; van der Zee, J1

Other Studies

1 other study(ies) available for azacitidine and Frontotemporal Lobar Degeneration

ArticleYear
Promoter DNA methylation regulates progranulin expression and is altered in FTLD.
    Acta neuropathologica communications, 2013, May-13, Volume: 1

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Animals; Azacitidine; Brain; Cell Line; CpG Islands; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; Enzyme Inhibitors; Female; Frontotemporal Lobar Degeneration; Gene Expression Regulation; HEK293 Cells; Humans; Intercellular Signaling Peptides and Proteins; Male; Mice; Middle Aged; Parkinson Disease; Progranulins; Promoter Regions, Genetic; RNA, Messenger

2013